IP Library Granted Patent US 7,177,695
Granted Patent B2
US 7,177,695 · App. 10/023,502 · Granted Feb 13, 2007

Early stage wound healing using electromagnetic radiation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,177,695
App. No.
10/023,502
Granted
Feb 13, 2007
Kind
B2
Abstract

A device and method is disclosed for the treatment of early stage wounds, i.e. those wounds that have resulted in little or no breach of the skin tissue. The invention utilizes non-ablative laser or non-coherent electromagnetic radiation applied to a stage one or two wound to stimulate wound healing, destroy viral and bacterial bodies, and prevent the development of such wounds into higher stage wounds. An appropriate wavelength is chosen from the range of 193 nm to 10.6 microns, and is delivered at a power density of about at least 1 W/cm 2 over a predetermined treatment duration typically in the range of 1 second to 3 minutes. To achieve the desired energy density, radiation is typically delivered at a power between 1 Watt and 15 Watts, with an average power of 5–10 Watts. Early stage wounds that can be addressed with this invention include but are not limited to spider or other insect bites, bee stings, rashes, eczema, psoriasis, and poison ivy. The present invention is especially useful for patients with a compromised ability to heal or stave off infection due to diabetes or other conditions.

Claims (6)

1. A method to prevent wound progression and enhance wound healing for stage 1 and stage 2 wounds by irradiating said stage 1–2 wound with directed non-ablative coherent radiation operating at one or more wavelengths around 980 nm, wherein said method uses at least one optical fiber connected to a source of coherent radiation to irradiate said wound.

2. A method to prevent wound progression and enhance wound healing according to claim 1 , wherein said method uses non-ablative coherent radiation having a power density of at least about 1 W/cm 2 for a preselected time of exposure in a range from 1 second to 3 minutes.

3. A method to prevent wound progression and enhance wound healing according to claim 2 , wherein said method uses non-ablative coherent radiation operating at about 980 nm.

4. A method to prevent wound progression and enhance wound healing according to claim 2 , wherein said method uses non-ablative radiation having an average power between 1 Watt and 20 Watts.

5. A method to prevent wound progression and enhance wound healing according to claim 2 , wherein said method uses non-ablative coherent radiation preferably having an average power between 5 and 10 W.

6. A method to prevent wound progression and enhance wound healing according to claim 1 , wherein said method also includes eradicating bacteria and viral bodies, thereby preventing infection.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2011
From: CERAMOPTEC INDUSTRIES, INC.
To: BIOLITEC PHARMA MARKETING LTD
Reel/Frame 027352/0591 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2001
From: MORAN, KELLY
To: CERAMOPTEC INDUSTRIES, INC.
Reel/Frame 012399/0664 →